Literature DB >> 24664690

Digital quantification of Goldmann visual fields (GVFs) as a means for genotype-phenotype comparisons and detection of progression in retinal degenerations.

Sarwar Zahid1, Crandall Peeler, Naheed Khan, Joy Davis, Mahdi Mahmood, John R Heckenlively, Thiran Jayasundera.   

Abstract

PURPOSE: To develop a reliable and efficient digital method to quantify planimetric Goldmann visual field (GVF) data to monitor disease course and treatment responses in retinal degenerative diseases.
METHODS: A novel method to digitally quantify GVFs using Adobe Photoshop CS3 was developed for comparison to traditional digital planimetry (Placom 45C digital planimeter; Engineer Supply, Lynchburg, Virginia, USA). GVFs from 20 eyes from 10 patients with Stargardt disease were quantified to assess the difference between the two methods (a total of 230 measurements per method). This quantification approach was also applied to 13 patients with X-linked retinitis pigmentosa (XLRP) with mutations in RPGR.
RESULTS: Overall, measurements using Adobe Photoshop were more rapidly performed than those using conventional planimetry. Photoshop measurements also exhibited less inter- and intraobserver variability. GVF areas for the I4e isopter in patients with the same mutation in RPGR who were nearby in age had similar qualitative and quantitative areas.
CONCLUSIONS: Quantification of GVFs using Adobe Photoshop is quicker, more reliable, and less user dependent than conventional digital planimetry. It will be a useful tool for both retrospective and prospective studies of disease course as well as for monitoring treatment response in clinical trials for retinal degenerative diseases.

Entities:  

Mesh:

Year:  2014        PMID: 24664690      PMCID: PMC4618319          DOI: 10.1007/978-1-4614-3209-8_17

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  5 in total

1.  Test-retest, within-visit variability of Goldmann visual fields in retinitis pigmentosa.

Authors:  Ava K Bittner; Mian Haris Iftikhar; Gislin Dagnelie
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-11       Impact factor: 4.799

2.  Non-linear projection of the retinal image in a wide-angle schematic eye.

Authors:  N Drasdo; C W Fowler
Journal:  Br J Ophthalmol       Date:  1974-08       Impact factor: 4.638

3.  Visual field area on the Goldmann hemispheric perimeter surface. Correction of cartographic errors inherent in perimetry.

Authors:  T H Kirkham; E Meyer
Journal:  Curr Eye Res       Date:  1981       Impact factor: 2.424

Review 4.  Autoimmune retinopathy: a review and summary.

Authors:  John R Heckenlively; Henry A Ferreyra
Journal:  Semin Immunopathol       Date:  2008-04-12       Impact factor: 9.623

5.  Management of autoimmune retinopathies with immunosuppression.

Authors:  Henry A Ferreyra; Thiran Jayasundera; Naheed W Khan; Shirley He; Ying Lu; John R Heckenlively
Journal:  Arch Ophthalmol       Date:  2009-04
  5 in total
  12 in total

Review 1.  Future opportunities in diabetic retinopathy research.

Authors:  Thomas W Gardner; Emily Y Chew
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2016-04       Impact factor: 3.243

2.  Variability and Errors of Manually Digitized Goldmann Visual Fields.

Authors:  Michael P Barry; Ava K Bittner; Liancheng Yang; Rebecca Marcus; Mian Haris Iftikhar; Gislin Dagnelie
Journal:  Optom Vis Sci       Date:  2016-07       Impact factor: 1.973

3.  Reliability of kinetic visual field testing in children with mutation-proven retinal dystrophies: Implications for therapeutic clinical trials.

Authors:  Vaidehi S Dedania; Jerry Y Liu; Dana Schlegel; Chris A Andrews; Kari Branham; Naheed W Khan; David C Musch; John R Heckenlively; K Thiran Jayasundera
Journal:  Ophthalmic Genet       Date:  2017-07-13       Impact factor: 1.803

4.  Peripheral Visual Fields in ABCA4 Stargardt Disease and Correlation With Disease Extent on Ultra-widefield Fundus Autofluorescence.

Authors:  Maria Fernanda Abalem; Benjamin Otte; Chris Andrews; Katherine A Joltikov; Kari Branham; Abigail T Fahim; Dana Schlegel; Cynthia X Qian; John R Heckenlively; Thiran Jayasundera
Journal:  Am J Ophthalmol       Date:  2017-10-14       Impact factor: 5.258

5.  Content generation for patient-reported outcome measures for retinal degeneration therapeutic trials.

Authors:  Gabrielle D Lacy; Maria Fernanda Abalem; Lilia T Popova; Erin P Santos; Gina Yu; Hanan Y Rakine; Julie M Rosenthal; Joshua R Ehrlich; David C Musch; K Thiran Jayasundera
Journal:  Ophthalmic Genet       Date:  2020-06-22       Impact factor: 1.803

6.  Real-world outcomes of voretigene neparvovec treatment in pediatric patients with RPE65-associated Leber congenital amaurosis.

Authors:  Callie Deng; Peter Y Zhao; Kari Branham; Dana Schlegel; Abigail T Fahim; Thiran K Jayasundera; Naheed Khan; Cagri G Besirli
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-01-10       Impact factor: 3.535

7.  Assessment of Glaucomatous Damage After Boston Keratoprosthesis Implantation Based on Digital Planimetric Quantification of Visual Fields and Optic Nerve Head Imaging.

Authors:  Mohsin H Ali; Mark S Dikopf; Anthony G Finder; Ahmad A Aref; Thasarat Vajaranant; Jose de la Cruz; Maria Soledad Cortina
Journal:  Cornea       Date:  2018-05       Impact factor: 2.651

8.  Visual Field Progression in Retinitis Pigmentosa.

Authors:  Manlong Xu; Yi Zhai; Ian M MacDonald
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-06-03       Impact factor: 4.799

9.  Quantification of RPE Changes in Choroideremia Using a Photoshop-Based Method.

Authors:  Yi Zhai; Manlong Xu; Ioannis S Dimopoulos; David G Birch; Paul S Bernstein; Jenny Holt; David Kirn; Peter Francis; Ian M MacDonald
Journal:  Transl Vis Sci Technol       Date:  2020-06-18       Impact factor: 3.283

10.  Correlation of Immunological Markers with Disease and Clinical Outcome Measures in Patients with Autoimmune Retinopathy.

Authors:  Lynn K Stanwyck; Weilin Chan; Arjun Sood; Gayatri Susarla; John Romano; Maria Pefkianaki; Kanishka Thiran Jayasundera; John R Heckenlively; Steven K Lundy; Lucia Sobrin
Journal:  Transl Vis Sci Technol       Date:  2020-06-16       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.